Beneficial effects of a gait used while wearing a kimono to decrease the knee adduction moment in healthy adults by Susumu Ota (4167205)

“…The 1^st and 2^nd peak KAMs were significantly decreased during Nanba walking (0.40±0.09 and 0.37±0.13 Nm/kg) compared with normal walking (0.45±0.09 and 0.45±0.13 Nm/kg; P = 0.002, P<0.001, respectively). …”

TGF-β1 increased the expression of biglycan and decreased the expression of decorin. by Youssef M. Farhat (295089)

Combined EGCG/As decreases the viability of two types of EC, HUVEC and HBMEC. by Jee-Youn Kim (796526)

SETD2 loss of function in BMSCs showed decreased bone mass. by Lijun Wang (176511)

Melatonin decreases the viability of BeWo cells under hypoxia/reoxygenation. by Lucas Sagrillo-Fagundes (6194843)

Blocking C5L2 decreased MPO concentration in the supernatant of C5a-primed neutrophils. by Jian Hao (160736)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…Treatment with GSK343 resulted in significantly decreased migration. (D) After 24 hours of treatment with increasing concentrations of GSK343 (0, 5, 10 μM), COA3 and COA6 cells (4.0 × 10⁴) were plated in Transwell^® inserts and allowed to invade for 1 week through a Matrigel^™ layer. …”

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

LPS dose-dependently decreases T cell proliferative response to OKT3. by Fanny Poujol (834338)

The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

“…<p>Myocardium was treated with the estrogen receptor-α agonist PPT (100 nM) for 1 (A) (N = 9), 2.5 (B) (N = 9), or 5 min (C) (N = 22). …”

WT1 mRNA and protein levels are decreased by GnRH. by Debalina Bagchi (686046)

PMC exhibits less sensitivity to decreasing signal-to-noise ratio (SNR) by Owen Puls (22340344)

Chronic RAS blockade decreases AT₁R expression. by Lai Ming Yung (353970)

App1 decreases the recovery time after amphotericin B treatment. by Muhammad Ghaffar (8082002)

Over-expression of rhodopsin decreased the expression levels of differentiation markers in NHEKs. by Hyoung-June Kim (459814)

Overexpression of active Fyn decreases clonogenicity in the absence of BCR-ABL1. by Melissa M. Singh (293682)

<i>E. faecalis</i> metabolism decreases after exposure to bilirubin. by Christopher L. Nobles (437464)

Treatment with HBOT or PFD decreased the frequency of mast cells in the AD lesions. by Hyung-Ran Kim (532404)

Treatment with HBOT or PFD decreased IFN-γ expression in the AD lesions. by Hyung-Ran Kim (532404)

IFNγ activates STAT signaling and decreases cell viability of NPCs. by Johanna Mäkelä (223358)